Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

TOMRA: Invitation to Q4 2018 presentation

TOMRA's fourth quarter 2018 results will be released Thursday 21st of February 2019. President & CEO Stefan Ranstrand and CFO Espen Gundersen will present the results at 08:00 CET. The presentation will be held in English and take place at Thon Hotel Vika Atrium, Oslo Norway (Meeting room: Nyland). The presentation will be webcasted live. Questions to the speakers can be directed using the Q&A-tool embedded in the webcast and will be addressed towards the end of the presentation. A recorded version of the webcast will be available shortly after the webcast has concluded. Link to

NATTO: STRONG GROWTH AND POSITIVE RESULT

Oslo, Norway (13 February 2019) - NattoPharma increased revenues by 52% in the second half of the year and delivered a positive net result in the half year and for the full year 2018. This is coupled with a strong financial position with no interest-bearing debt and an equity ratio of 74,5% as at December 31st, 2018. “We are very pleased to deliver a strong second half fueled by a record fourth quarter with Product Revenues of approximately NOK 31 million and an EBITDA of 10%. This is the first full year where the Group has a positive net result, demonstrating our ambition of profitable

MUNTERS FOURTH QUARTER AND FULL YEAR 2018

Fourth quarter 2018 · Order intake decreased by 4% to SEKm 1,753 (1,821). The fourth quarter 2017 included a SEKm 450 Data Center order. · Net sales increased by 1% to SEKm 1,834 (1,811). · Operating profit (EBIT) amounted to SEKm -256 (127). · EBIT included a SEKm -323 write-down of goodwill related to Data Centers. · Adjusted EBITA decreased by 11% to SEKm 154 (174), corresponding to an adjusted EBITA margin of 8.4% (9.6). · Net income was SEKm -321 (152). · Cash flow from operating activities was SEKm 441 (-8). · Earnings per share amounted to SEK -1.78 (0.83).

Invitation to Essity’s Investor Day 2019

Essity, a leading global hygiene and health company, invites investors, analysts and media to an investor day in Stockholm on May 23, 2019. Presentations will be held by President and CEO Magnus Groth, other members of the Executive Management Team and representatives from Vinda.Essity’s vision is: Dedicated to improving well-being through leading hygiene and health solutions. During its investor day, Essity will describe its strategic work for achieving its vision and continuing to deliver profitable growth. The work on launching successful innovations, building our brands, improving

Vicore Pharma postpones publication of year-end report

Mölndal, February 13, 2019 - Vicore Pharma Holding AB (publ) has decided to postpone the publication of the year-end report for 2018. The year-end report will be published on March 15, 2019, instead of previously announced February 22, 2019.The reason for postponing the report is the decision to convert the company’s accounting principles to IFRS as per the year-end report for 2018. Conversion to IFRS is an important part of the preparations for the up-listing to the Stockholm Nasdaq main list which is planned to take place during the second half of 2019. For further information, please

Year-end report 2018

Net sales increased sharply during the quarter to SEK 37.8 million (11.1) due to increased deliveries. Net sales for the full year amounted to SEK 58.9 million (11.9). Order intake for the fourth quarter amounted to SEK 40.0 million (12.6). In total, the order backlog amounted to SEK 818.6 million (353.7) by the end of the year. During the quarter many modules have been delivered to customers within Maritime. Within the geothermal segment, focus continues to be on Japan and Iceland, where Varmaorka is now conducting final tests of their first power plant which has begun delivering electricity

Q4 2018: Growth in fourth quarter closes the year

Significant events in the fourth quarter• Fourth-quarter net sales rose to MSEK 163, up 36%, or MSEK 43 compared with the year-on-year period, due to continued recovery from a customer-specific destocking programme• First commercial order after the introduction of Probi’s product to improve bone health in postmenopausal women – Probi® Osteo• Promising initial results from clinical trials to evaluate the effects of Probi’s strains on physical performance and acute stress• Tom Rönnlund appointed new CEO as of January 1, 2019 and Henrik Lundkvist new CFO as of January 7, 2019• Board

Chanel store expansion in Stockholm

During 2019, Chanel will expand its store space in the Hufvudstaden property at Birger Jarlsgatan 7 in Bibliotekstan. The store will increase in size from the current 200 square metres to around 500 square metres spread over two floors. The newly expanded store is expected to open in autumn 2019.  “Hufvudstaden’s aim is to offer successful retail and office tenants prime business locations in central Stockholm and central Gothenburg. We are therefore extremely pleased that Chanel has chosen to broaden its operations in a Hufvudstaden property in Bibliotekstan,” says Ivo Stopner,

Correction of error Q3 (18) report

Lund, Sweden, 08.00 CET, February 13, 2019 - BONESUPPORT ™, an emerging leader in orthobiologics for the management of bone voids, today announces that the report for the third quarter of 2018, published November 7, 2018, contained an error that arose in connection with the transition to a new reporting system. Due to the error, gross profit and the result for the third quarter of 2018 have been reported as SEK 1.3 million too high. The error relates in its entirety to the segment EUROPE & REST OF WORLD. The error refers to internal profit calculation in inventories and was discovered

Demeter Finance has solicited interest among certain holders of the senior secured callable fixed rate bonds due 2020 issued by DDM Debt AB to consent to a waiver and certain amendments to the bonds

THE OFFER IS NOT BEING MADE, AND THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO, NOR WILL ANY TENDER OF SHARES BE ACCEPTED FROM OR ON BEHALF OF HOLDERS IN, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA OR THE UNITED STATES OF AMERICA, OR ANY OTHER JURISDICTION IN WHICH THE MAKING OF THE OFFER, THE DISTRIBUTION OF THIS PRESS RELEASE OR THE ACCEPTANCE OF ANY TENDER OF SHARES WOULD CONTRAVENE APPLICABLE LAWS OR REGULATIONS OR REQUIRE FURTHER OFFER DOCUMENTS, FILINGS OR OTHER MEASURES IN ADDITION TO THOSE REQUIRED UNDER SWEDISH LAW.On 17 December

Quimper declares the offer for Ahlsell unconditional and will acquire all tendered shares

This announcement is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdictions where such offer pursuant to legislation and regulations in such relevant jurisdictions would be prohibited by applicable law. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled “Important notice” at the end of this announcement and

RepRisk releases its Most Controversial Projects of 2018 Report–three of ten projects highlight the Food and Beverage sector’s significant exposure to ESG risks.

The latest issue of RepRisk’s report focuses on projects such as factories, dams, and ships that posed serious reputational, compliance, and financial risks in 2018 for the companies involved.Zurich, Switzerland – February 13, 2019 - RepRisk’s Most Controversial Projects of 2018 Report focuses on the ten projects that were most exposed to ESG (environmental, social, and governance) and business conduct risks last year. The projects ranked in the report are located in both developed and emerging markets, and stem from a range of sectors, while three projects in this year’s issue were linked

Pricer AB: StrongPoint Signs Agreement in the Baltics for Delivery of Pricer’s system

Pricer’s reseller StrongPoint has signed an agreement with one of the largest grocery chains in the Baltics for delivery, installation and service of Pricer’s system with digital price labels. The first part of the agreement consists of one pilot store in each of the three Baltic countries, with a subsequent potential of delivery to all stores in the chain. The agreement covers a partial deployment with labels for certain sections of the stores. The estimated value of the agreement is up to SEK 15 million. Deliveries will begin in 2019 and be completed before the end of 2020. The order

National Museum of Science and Technology and Stora Enso build Stockholm’s smartest wooden building

STORA ENSO OYJ PRESS RELEASE, 13 February 2019, 09:00 EETWith Stora Enso as the principal partner and donations of SEK 85 million, Tekniska Museet – Sweden’s National Museum of Science and Technology – is mustering forces to create a digital, interactive learning and test environment for scientific communication: Wisdome. This is one of the single most important initiatives at the National Museum of Science and Technology since it was founded almost 100 years ago. An innovative, sustainable new wood building is to be erected for the purpose. Using state-of-the-art Swedish visualisation

BioArctic’s product candidate SC0806 for treatment of patients with complete spinal cord injury is now in Phase 2

Stockholm, Sweden, February 13, 2019 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the first patient in the second panel of the Phase 1/2 study now has been treated with SC0806. This means that the study with the product candidate SC0806 for complete spinal cord injury has progressed into Phase 2. BioArctic develops a new innovative treatment for patients with complete spinal cord injury. The product candidate SC0806 is a combination of a biodegradable medical device and a drug substance (FGF1). SC0806 is designed to support nerve regeneration across the injured

Grethe Bergly appointed new CEO of Multiconsult ASA

The board of directors has appointed Grethe Bergly as new Chief Executive Officer (CEO) of Multiconsult ASA as of 1 March 2019. Acting CEO Lars Opsahl will return to the position of EVP Regions Norway at the same date.“We are happy to announce Grethe as the new CEO for the Multiconsult group. With her experience, expertise and leadership qualities she will make a positive contribution to the further development of Multiconsult in accordance with the strategy”, says Mr. Bård Mikkelsen, Chairman of the board. Grethe Bergly has been with Multiconsult since 2002 and has held various

CLX Communications AB (publ): CLX Communications unifies its business under a shared identity and rebrands as Sinch

Stockholm, Sweden - CLX Communications AB (publ) - XSTO: CLX CLX Communications AB, a global leader in cloud communications for mobile customer engagement, today announced the launch of a new corporate brand identity with a shared name and visual identity for all business units. Products that were previously marketed under the CLX, Symsoft, Sinch, and Vehicle brands are now integrated into a unified offering. "We are redefining how businesses engage with their customers through cloud-based tools and mobile technology. We want our brand to expose the full width of our product portfolio

NATTOPHARMA ENHANCES OFFERING WITH TECHNOLOGY PARTNERSHIP

The world leader in Vitamin K2 expands its product portfolio, developing a new ingredient with a technologically advanced delivery system for fast-growing, dynamic supplement categoriesOslo, Norway (13 FEB 2019) — NattoPharma has reached an accord with Inventia Healthcare Ltd. and Laila Nutraceuticals that provides NattoPharma with the exclusive rights in core markets to add Inventia and Laila’s proprietary ingredient, in the mood and energy segments, supported by unique composition of actives and proprietary novel technology, to its clinically validated portfolio.   Not only does the

The world’s rarest chocolate returns to Fazer – Fazer Pure Ruby is available again

Fazer has brought out a limited edition of Fazer Pure Ruby chocolate. The previous batch of Pure Ruby chocolate sold out in just three days. These rare bars of Fazer Pure Ruby chocolate are only available from Fazer’s own sales outlets: the Fazer Experience visitor centre, Fazer Cafés and the online Fazer Candy Store.Known as the rarest chocolate in the world, ruby chocolate is a new variety of chocolate launched in 2017.It is made from special rubycocoa beans using a unique manufacturing method. Rubychocolate combines the qualities of dark chocolate, milk chocolate and white chocolate,

Mineral Resources and Mineral Reserves, 2018

Successful exploration work at Tara continued in 2018, with no other major contributions to report. Exploration drifts are under development at Tara and Kristineberg in order to establish improved locations for drill towards the new mineralisations. Garpenberg, Aitik and Kevitsa have Mineral Resources and Mineral Reserves sufficient to secure production for many years to come.“We are continuing to focus our exploration activities on existing mine-site areas. Developments around Tara continue to look promising, and we are looking forward to establishing new drilling positions in the Boliden

Boliden’s fourth quarter: Stable production, lower grades and metal prices

Boliden’s revenues for the fourth quarter of 2018 totalled SEK 12,543 m (13,619), and the operating profit was SEK 2,093 m (3,091). The revenues and operating profit for the year as a whole were SEK 52,454 m (49,531) and SEK 9,004 m (9,015), respectively.“The end of a strong year was characterised by stable production on the part of both of our business areas. Grades were lower than the very high levels seen last year at several of our mines. However, metal production at our smelters was slightly higher than last year,” says Boliden’s President & CEO, Mikael Staffas. Boliden Mines’

Thule Group CEO and President Magnus Welander comments on the Year-end report, fourth quarter, October-December 2018

Strong growth for the quarter and full yearAfter the fourth quarter, we can summarize another year of healthy sales growth of 6.0 percent and high profitability, with an EBIT margin of 18.0 percent. This is despite the fact that we invested 6 percent of sales in product development, which is in line with our focus on long-term organic growth.Sales in the fourth quarter climbed to SEK 1,157m (1,006), an increase of 15.0 percent (8.0 percent after currency adjustment). During the quarter, EBIT declined SEK 1m, which was in line with our expectations. Factors that impacted profitability were

Board proposes automatic share redemption procedure

Boliden has generated substantial cash flows over the past year, and the financial position is strong. The balance sheet is stronger than Boliden’s target of around 20 percent debt during an economic upturn. The goal has been specified to include net reclamation liability. The Board of Directors intends, therefore, to propose that the AGM approve an extra dividend payment of SEK 4.25 per share by means of an automatic share redemption procedure.The Board of Directors’ proposal, which will jeopardise neither Boliden’s ability to handle any deterioration in market terms nor to finance

Q4 Interim Report and Year-end report for 2018

Q4 2018 · Revenues totalled SEK 12,543 m (13,619)  · The operating profit totalled SEK 2,093 m (3,091) · The operating profit, excluding the revaluation of process inventory, totalled SEK 2,001 m (2,912)  · Free cash flow totalled SEK 1,721 m (2,382) · Earnings per share totalled SEK 6.82 (8.22) Stable production, lower grades and metal prices · Stable production in Smelters. · Stable mined production, but with lower grades. · The net debt/equity ratio decreased during the quarter from 10% to 5%. · The Board of Directors proposes a payment to the

There are no items matching the current filter
There are no more items matching the current filter
Back to top